DE2011376C3 - - Google Patents

Description

RNH

IO

in which R is an acyl group which is stable under the reaction conditions and R 'is a common, light one is removable residue of an alcohol or phenol, by rearrangement of a 6 ^ -acylamidopenicillanic acid 1-oxide ester the general formula

20 O

RNH-T / ^S '

O =! - N

The compounds mentioned in the specification are used in relation to penicillanic acid and cepham

designated.

Penicillanic acid has the following structure:

O = ¹

CH ₃

CH ₃
COOH

and Cepham has the following structure:

(Π)

at an elevated temperature in an inert organic solvent and in the presence of a Catalyst, characterized in that the rearrangement in the presence of 0, Ul up to 0.2 mol of a salt of pyridine, quinoline, isoquinoline, 8-hydroxyquinoline or benzimidazole, one by a methyl, formyl, acetyl, acetamido, cyano, carboxy or aidoximino group or by a chlorine or bromine atom substituted pyridine, quinoline, isoquinoline or Benzimidazole, or from aniline, chloroaniline, lower alkyl aniline, N-lower alkyl aniline, hydroxyaniline, Lower alkoxyaniline, carboxyaniline, m-nitroaniline, sulfaniline or benzylamine and a lower alkyl, a lower alkyl, phenyl lower alkyl, benzene, Bromobenzene or nitrobenzene phosphonic acid, phosphoric acid, pyrophosphoric acid, phosphorous Acid, trifluoroacetic acid, methanesulfonic acid, p-toluenesulfonic acid, p-xylenesulfonic acid, naphthalene-2-sulfonic acid, or pyridyl sulfonic acid per mole of the penicillin sulfoxide ester, the salt being in situ in the reaction mixture can be formed.

2. The method according to claim 1, characterized in that the rearrangement is carried out in the presence of a salt carried out in situ by the conversion of essentially molar equivalents obtained from pyridine and orthophosphoric acid.

3. The method according to claim 1, characterized in that the rearrangement is carried out in the presence of a salt carried out by reacting essentially molar equivalents is formed by pyridine and dichloromethanephosphonic acid.

4. The method according to claim 1, characterized in that the rearrangement is carried out in the presence of a salt carried out by reacting approximately two molar equivalents of (cf. J.A.C.S. 1962, 84, 3400, and J. Chem. Soc. 1965, 5031).

The term "cepham" refers to the basic cepham framework with a simple olefinic one Double bond.

Cephalosporin antibiotics are of great interest as a number of them are used in the treatment of Infections that are caused by pathogenic bacteria and some of which are versus others Antibiotics are resistant, have valuable properties. Penicillin compounds are now in larger quantities produced on an industrial scale than Cephalosporinverbindungen.und by the With the ever increasing interest in cephalosporin compounds it is very desirable to use other methods for the production of the latter, as a simple process of conversion of penicillin-like compounds in cephalosporins.

The invention is therefore concerned with the conversion of 6 / I-acylamidopenicillanic acid 1-oxide esters into Tfi - acylamido - 3 - methylceph - 3 - em - 4 - carboxylic acid esters.

In U.S. Pat. No. 3,275,626 a general Process for the preparation of antibiotic compounds including cephalosporins described, which consists in the fact that so-called penicillin sulfoxide can be used under acidic conditions heated to a temperature of about 100 to about 175 ° C, but not a satisfactory one Yields can be achieved.

The invention relates to a new process for the rearrangement of 6/3-acylamidopenicillanic acid 1-oxide esters (hereinafter referred to as penicillin oxides for the sake of simplicity) in 7 /? - Acylarnido-3-methylceph-S-em ^ carboxylic acid ester. It has been found that the rearrangement can be carried out in good yield by certain compounds, which are available as salts or complexes present, is effected.

ftas. methods of manufacture according to the invention M ^ aiylamido - 3 - methylceph - 3 - em - 4 - carbon - '* " stone of the general formula

RNH

COOR '

If R is an oil group which is stable under the reaction conditions and R 'is a common, easily cleavable alcohol or phenol, through the allocation of an o / I-acylamidopenicillanic acid 1 -oxide
^{A of} the general formula

RNH

COOR '

| iei elevated temperature in an inert organic solvent and in the presence of a catalyst, Is characterized in that the rearrangement in the presence of 0.01 to 0.2 mol of a salt of fyridine, quinoline, isoquinoline, 8-hydroxyquinoline or benzimidazole, one by a methyl, For-Kjyl, Acetyl, acetamido, cyano, carboxy or aldoximino groups or by a chlorine or bromine atom substituted pyridine, quinoline, isoquinoline eder BenzimidaEol, or from aniline, chloraniline, Lower alkyl aniline, N-lower alkyl aniline, hydroxyaniline, Lower alkoxyaniline, carboxyaniline, m-nitroaniline, sulfaniline or benzylamine and a lower alkyl, a lower alkyl, phenyl lower alkyl, benzene, bromobenzene or Nitrobenzenephosphonic acid, phosphoric acid, eyrophosphoric acid, phosphorous acid, trifluoroacetic acid, Methanesulfonic acid, p-toluenesulfonic acid, p-xylene sulfonic acid, naphthalene-2-sulfonic acid or Pyridylsulfonic acid per mole of the penicillinsulfoxydester carried out, the salt in situ in the reaction mixture can be formed.

It is not certain in every case whether the salts mentioned above are true salts or complexes. For example, the reaction of pyridine with orthophosphonic acid yields a crystalline material which has the analysis C ₅ H ₅ N · 2H3PO4. For convenience, these compounds are described as salts, although it should be noted that the term "salts" may be replaced by the term "complexes". Furthermore, the salt or the complex can be present in dissociated form under the reaction conditions.

Examples of the above-mentioned phosphonic acids include methane phosphonic acid ethane phosphonic acid, Dichloromethanephosphonic acid, trichloromethanephosphonic acid and iodomethane phosphonic acid.

Examples of lower alkyl compounds that can be used are o-methylaniline and m-methylaniline; an example for Lower alkoxyaniline is o-methoxyaniline; <: in example for carboxyanilines is m-carboxyaniline and an example of N-lower alkyl anilines is N-methylaniline.

Preferred classes of the salts mentioned are those obtained by reacting, for example, in im substantial molar equivalents of acid and base are obtained. Favorable results have been made obtained in the process according to the invention when using salts of orthophosphoric acid or eiuer

of the phosphonic acids mentioned used as a catalyst.

The salts that can be used in the process of the invention can be obtained by a Quantities of the acid and the base are formed so that one or more of the acid function (s) is exactly neutralized by the base. In general, it is preferred to have molar equivalents of the base and the acid to use. If desired, however, molar proportions can differ from those given above may be used, for example, a less than molar amount of the nitrogen base can be used use so that in addition to the salt, the catalyst also contains some free acid. Alternatively, one can use more than the molar amount of nitrogen base using a salt whose average composition corresponds to an intermediate product that is between a mono- or di- (nitrogen base) salt. The base can be present in excess, based on to the total molar amount required to neutralize the acid function (s), but it should not be used in excessive excess, for example it generally should not be used in amounts exceeding a molar excess and more, and consequently this excludes the use of the base as a solvent in the reaction.

The optimal ratio of acid to base depends on several factors, such as the type of Acid and base, as well as the type of penicillin oxide. The optimal ratio can be determined by preliminary tests and preliminary experiments are determined.

A preferred salt for use in the process of the invention is that in situ in the reaction mixture by reacting essentially molar equivalents of pyridine and Orthophosphoric acid receives. Other preferred salts for use in the method of the invention are formed from pyridine and dichloromethanephosphonic acid. One is obtained by one converts essentially molar equivalents of pyridine and dichloromethanephosphonic acid, and it will hereinafter referred to as monopyridinium dichloromethane phosphonate. Another is obtained through Reaction of essentially 2 moles of pyridine with 1 mole of phosphonic acid, and it is hereinafter referred to as Referred to as dipyridinium dichloromethane phosphonate.

The salts of the above nitrogen bases and the above phosphonic acids are new compounds.

Monopyridinium dichloromethane phosphonate can be made by slowly adding pyridine a solution of dichloromethanephosphonic acid in a polar solvent (e.g. a Ketone, such as acetone or a lower alkanol, such as methanol, ethanol, n-propanol or isopropanol) admits. Monopyridinium dichloromethane phosphonate is a stable colorless crystalline solid, which melts at 142 to 145 ° C.

Other preferred salts are disclosed in the examples.

The; The process according to the invention is carried out in an organic solvent, since the

Want to control reaction conditions, such as temperature, more precisely. Generally this is penicillin oxide be dissolved in the organic solvent. The solvent should be used against the penicillin oxide, that is used in the process and versus the cephalosporin compound that is used in formed in the process will be essentially inert.

Solvents that can be used include those mentioned in U.S. Patent 3,275,626 and other publications describing the rearrangement reaction. However, particularly suitable solvents ketones which boil between 75 and 120 ⁰ C (for example, 100 to 120 ⁰ C), esters 75 to 140 ⁰ C (for example from 100 to 130 ⁰ C), dioxane and Diäthylenglykoldimethyläiher (diglyme). Examples of these ketones and esters which can be used in the process of the present invention are aliphatic ketones and esters which have a suitable boiling point including ethyl methyl ketone, isobutyl methyl ketone, methyl n-propyl ketone, n-propyl acetate, n-butyl acetate, isobutyl acetate , sec-butyl acetate and diethyl carbonate.

The time required to achieve optimal yields in the process of the invention obtained depends on the particular solvent chosen. The rearrangements are made with the The boiling point of the chosen solvent and for those solvents that are in the low Boiling part of the range given above, can correspondingly longer reaction times, for example up to 48 hours, may be required compared to solvents used at higher temperatures boil. Rearrangements in dioxane generally require 7 to 15 hours to get the best results to obtain, whereas rearrangements that are carried out in methyl isobutyl ketone, in general Require times from 1 to 8 hours. The yields in the rearrangements depend in to a lesser extent also on the concentration of the catalyst in the solvent, so are accordingly longer reaction times required for lower catalyst concentrations.

It is particularly preferred to use dioxane as the organic solvent. Penicillin oxides can can be dissolved in this solvent at a high concentration and, in general, the yield drops by increasing the concentration in the range of 35% does not decrease.

The salts used in the process of the invention show relatively low levels Color during rearrangement compared to similar rearrangements that occurred in the presence of an acidic Catalyst, such as a hydrocarbyl sulfonic acid, are carried out. By-products in general are formed by such acidic catalysts, apparently only occur to a small extent, and the use of the salts has the practical advantage that under the preferred conditions it it is not necessary to use reagents for decolorizing and agents to bind the acid before the Reaction solvent is removed.

The appropriate length of time for a particular response can be determined by looking at the Test the reaction solution using one or more of the following methods.

1. Thin layer chromatography, for example on silica gel, developing with a 2: 1 mixture of benzene and ethyl acetate and making the stains visible by treatment with an iodine / azide solution (Russell, Nature, 1960, 186, 788). If, for example, the 2,2,2-trichloroethyl ester of 6p - phenylacetamido - penicillanic acid 1 / i-oxide is used _{from the starting material, the product (R F} 0.65) shows an orange-brown color, whereas the starting material (R _F 0.5) is dark yellow in color.

2. Determination of the rotation after suitable dilution of the reaction mixture with, for example Chloroform. If the same starting material is used as in 1, the rotation falls to approximately a third to a quarter of their original value.

3. Determination of the ultraviolet spectrum of a sample of the reaction mixture treated with ethyl alcohol has been appropriately diluted. If the same starting material is used as in 1, the calculated one increases Value for E! * "At 264 mm to about 100 at one successful response. Absorption maxima at higher wavelengths are preferably low or not available. This provision cannot be used when ketones are used as solvents can be used in the reaction medium.

Although satisfactory yields can be obtained if the reaction is carried out at normal reflux executes, it may be possible to improve the yields by using a drying or water-binding agent (e.g. aluminum oxide, calcium oxide, sodium hydroxide or molecular sieves) used, which is inert to the solvent at the reflux conditions remove the water formed during the reaction. Alternatively, this can be done during Water formed during the reaction can be removed using a fractionating column, wherein the water formed is removed by fractional distillation.

After completion of the reaction, the salt can either before or after the concentration of the Graze away reaction mixture. If the reaction solvent is immiscible with water, the salt can be removed by a simple washing process. On the other hand, if the reactant is miscible with water, a suitable cleaning method is to use the reaction solvent to remove (this can be achieved by distilling under reduced pressure) and then the residue by an ordinary method such as chromatography Purify silica gel.

It has been found that the degree of conversion achieved by the process of the invention is achieved, so that complicated cleaning processes can be avoided and that the product is obtained in a substantially pure form after a simple crystallization process.

Preferably, however, the product is isolated by adding the reaction mixture to water, the product is filtered off and, if desired, this by recrystallization from or slurrying in further cleans with a suitable solvent.

If preferred catalysts are used, for example pyridinium phosphate or monopyridinium dichloromethane phosphonate in dioxane solution, it may be sufficient to distill off only the solvent and the product of a suitable

Crystallize solvent to obtain a substantially pure product in high yield.

A step to remove discoloration, for example by treating with activated carbon, can be used. However, this is generally the case the preferred reaction conditions are not necessary.

The penicillin oxide used as starting material in the process according to the invention can of a salt of 6 / i-phenylacetamido-penicillanic acid or 6 / i-phenoxyacetamido-penicillanic acid derived, for example, by a fermentation process, esterification of the carboxyl group in the 3-position of penicillanic acid and oxidation of the sulfur atom in the 1-position. Alternatively, the penicillin oxide can be obtained from 6/9 aminopenicillanic acid by acylation of the amino group in the 6-position, esterification of the carboxyl group in the 3-position and oxidation of the sulfur in the 1-position.

The oxidation can be carried out as described by C h ο w, Hall and Hoover (J. Org. Chem. 1962, 27, 1381). The penicillin compound is mixed with the oxidizing agent in an amount so that at least one atom of active Oxygen is present per atom of the thiazolidine sulfur. Suitable oxidizing agents include a metaperiodic acid, peracetic acid, monoperphthalic acid, m-chloroperbenzoic acid and tert-butyl hypochlorite, the latter preferably in a mixture with a weak base, for example Pyridine is used. An excess of oxidizing agent can lead to the formation of 1,1-dioxide stir. The 1-oxide can be in the «- and / or / f-form can be obtained.

Acyl group in the 6 / i-amino position of penicillin oxide can be any desired acyl group that is stable under the rearrangement conditions. Suitably the acyl group is in the 6 / i position that of a penicillin obtained in the fermentation process, for example the phenylacetyl or phenoxyacetyl group. Such a group may not be the desired group in the final cephalosporin product but this can be achieved by making conversions like those below are described. Another acyl group which can be suitably used is the formyl group.

Alternatively, the acyl group at the 6β-position of the penicillin oxide can be that in the cephalosporin compound is desired, for example a thienylacetyl or phenylglyoxyl group, or it can be a Be a precursor for the desired acyl group, for example an acyl group, the protected functional Contains groups such as a protected amino group. An example of such an acyl group is a protected α-aminophenylacetyl group.

The amine protective group is suitably one which can subsequently be split off by reduction or hydrolysis without attacking the rest of the molecule, especially the lactam and 7/3 amidobine fertilizers of the cephalosporin compound formed. A similar protecting group can also be used as the esterifying group at the 3-COOH position, and both groups can be removed simultaneously as described below. One suitable method is to remove both groups in the final stage of the multi-step process. Protected groups include urethane, arylmethyl (e.g. trityl) amino, arylmethyleneamino, sulfenylamino and enamines. Such groups can generally be removed with one or more reagents selected from dilute mineral acids, e.g. dilute hydrochloric acid, concentrated organic acids, e.g. concentrated acetic acid, trifluoroacetic acid and liquid hydrogen bromide, at very low temperatures, e.g. -80 ° C. A suitable protecting group is the tertiary butoxycarbonyl group, which can easily be removed by hydrolysis with dilute mineral acid, for example dilute hydrochloric acid or preferably with a strong organic acid (for example formic acid or trifluoroacetic acid), for example at a temperature of 0 to 40 ⁰ C, preferably at room temperature (15 to 25 ⁰ C). Another suitable protective group is the 2,2,2-trichloroethoxycarbonyl group, which can be split off by zinc in acetic acid, formic acid, a lower alcohol or pyridine.

The ester of penicillanic acid is formed with an alcohol or a phenol, which is easily split off can be, for example, by hydrolysis or reduction, during a later stage to subsequently to deliver the Ceph-3-em compound formed as a free acid. Alcohol and phenol residues that easily can be split off include such. the electron withdrawing substituents, for example Contain sulfo groups or esterified carboxyl groups, these groups subsequently replaced by alkaline Reagents can be split off. Benzyl and o-benzyloxyphenoxy ester groups can be split off by hydrogenolysis, although this can result in poisoning of the catalyst. A preferred method of removal is cleavage with acid, and groups created by acid Cleavage that can be removed are adamantyl, tert-butyl. Benzyl groups such as the anisyl group and the radicals of alkanols which contain electron donors in the α-position, such as acyloxy, alkoxy, Benzoyloxy, substituted benzoyloxy, halogen, alkylthio, phenyl, alkoxyphenyl, or aromatic heterocyclic groups.

These residues can differ from benzyl alcohol. like ρ - methoxybenzyl alcohol, di - ρ - methoxyphenylmethanol, Triphenyltanol, diphenylmethanol, benzoyloxymethanol, benzoylmethanol, p-nitrobenzyl alcohol and derive furfuryl alcohol.

Alcohol groups that can then easily be split off with a reducing agent are those that differ from 2,2,2-trihaloethanol, for example 2,2,2-trichloroethanol, p-nitrobenzyl alcohol or 4-pyridylmethanol. 2,2,2-trihaloethyl groups can expediently by zinc / acetic acid, zinc / formic acid, zinc / lower alcohol or zinc / pyridine or can be removed by chromium (II) reagents. p-Nitrobenzyl groups are expediently by hydrogenolysis and 4-pyridylmethyl groups, expediently by electrolytic Reduction removed.

Where the ester group is subsequently removed by an acid catalyzed reaction, this can be can be achieved by using formic acid or trifluoroacetic acid (preferably in combination with anisole) or, alternatively, hydrochloric acid, for example mixed with acetic acid.

609 615/120

It is particularly preferred to use penicillin oxides in the process according to the invention which have a diphenylmethoxycarbonyl, a 2,2,2 - trichloroethoxycarbonyl, a tert. - Buloxycarbonyl, a p-nitrobenzyloxycarbonyl, benzoylmethoxycarbonyl or p-methoxybenzyloxycarbonyl group in the 3-position, since the Ceph-3-em compounds that are formed by esters of this type obviously do not have any remarkable I ³ - + ^ Isomerization.

Where the product of the rearrangement is a 7 / i-acylamidoceph-3-em compound which does not contain the desired acyl group, the 7 / i-acylamido compound can be N-deacetylated, if desired _t5 after reactions at other positions on the molecule, around the to provide the corresponding 7 / i-amino compound, and the latter can be acylated with a suitable acylating agent.

Process for the N-deacylation of cephalosporin derivatives, which have a 7 / i-acylamido group are known, and suitable methods are that you have a 7 / ^ - Acylamidoceph-3-em-4-carboxylic acid ester treated with an imide halide forming agent, the imide halide thus obtained in the Imino ethers are converted and the latter decomposed. If desired, the ester group can be hydrolysed or hydrogenolysis, the 4-carboxylic acid being obtained.

Suitable imide halide forming compounds include acid halides, which are different from phosphoric acids derive. The preferred compounds are the chlorides such as phosphorus oxychloride or phosphorus pentachloride.

The process for N-deacylation is described in more detail in Belgian patent 7,19,712. The N-deformylation a 7 // - formamido group can with mineral acids at a temperature of -15 to 100 ^0C, preferably +15 to 40 ° C is performed. A suitable reagent for N-deformylation is concentrated hydrochloric acid in methanol or, preferably, in dioxane or tetrahydrofuran, since undesired transesterification reactions which can occur in methanol are avoided in the latter solvent.

The following examples illustrate the invention. In the examples, unless otherwise stated, thin layer chromatography (TLC) is carried out on silica gel using a mixture of Benzene and ethyl acetate (2: 1) used as solvents for developing and the stains with iodine / Azide solution made visible.

example 1

2,2,2 - trichloroethyl - 6ß - phenylacetamido - penicilIanat-l /? - oxide (19.28 g, 40mmol) were dissolved in warm dioxane (400 ml). Pyridine phosphate (C ₅ H _{5 N -2HaPO 4} ; 0.704 g, 2.56 mmol) was added and the solution was refluxed for 16 hours in an apparatus designed so that the condensed solvent was replaced by calcium oxide (2.8 to 1.40 mm, about 40 g) before re-entering the reaction vessel. ' ₆ ,

The cooled mixture was evaporated in vacuo to give a gummy Mass obtained with warm ethyl alcohol

(technical, denatured) was treated. A solid crystallized and the mixture was refrigerated for 3 hours and filtered. The collected solid was washed with ethyl alcohol (10 ml and diethyl ether (20 ml) and dried, whereby the 2,2,2-trichloroethyl-3-methyl-7 / <- phenylacetamidocephO-em ^ -carboxylate was obtained (12.4 g 66 , 9% of theory), [«]" + 51.9 ° (C, 1.0 in CHCl ₃ ), melting point = 162 to 164 ° C.

A second batch (1.65 g, 9% of theory) was obtained from the mother liquors. [ «]" + 52.6 ° (C, 1, C InCHCl _3), mp. = 160-161 ⁰ C.

Example 2

A mixture of 2,2,2-trichloroethyl-6 / i-phenylacetamido-penicillanate-1 / foxyd (4.82 g, 10 mmol) pyridine (0.078 g, 1 mmol), orthophosphoric acid 'specific gravity 1.75, 0.112 g, 1 mmol) and Iso butyl methyl ketone (200 ml) was refluxed for 3 hours. The solution was starting cooled and then washed with water (1 100 ml, 1 χ 50 ml. The organic phase was reduced under reduced Pressure evaporated and the resulting gummy residue in ethyl alcohol (techn. Denat. 20 ml).

The solution was evaporated to dryness and the solid residue was triturated with ethyl alcohol (techn denate, 15 ml). The suspension was ^{stored at 0 °} C. for 16 hours and filtered. The collected solids were washed with ether and dried, the 2,2,2-trichloroethyl 3-methyl-7 / i-phenylacetamidoceph-3-em-4-carboxyate (3.20 g, 69.0% of theory) received, m.p. = 161 to ¹⁶² ^ M? + 52.1 ° (C. 1.0 in CHCl ₃ ).

Example 3

2,2,2 - Trichloroethyl - 6 / i - phenylacetamidopenicillanate 1 / i-oxide (4.82 g, 10 mmol) and pyridinium methanesulfonate (0.175 g, 1 mmol) were dissolved in hot isobutyl methyl ketone (200 ml) with IV for ₂ hours heated to reflux. The solution was cooled and washed with water (1 × 50 ml and 1 × 25 ml) before it was evaporated to dryness under reduced pressure. ^{The semi-crystalline} gum that remained was washed with ethyl alcohol (techn. Denat ..;, n? Y? Meben and stored in the refrigerator for 4 hours. The solid material was separated off by filtration, washed with ethyl ether (20 ml) and dried in vacuo the 2,2,2-trichloro- 2,1 κ ³ -J ^neth X ^l · ¹ P - Phenylacetamidoceph - 3 - em-Fn Ä ^ ⁷⁹⁸ ' ⁶⁰ ' ^1% of theory). Mp_ = 160b.s 161 ° C, [a] _D + 55.5 ° (CHCl ₃ , C = 1.0).

Fn-, 2EJ? ^Ch rse (0.1 g. 2.2% of theory. V-- ίου C) was isolated from the mother liquors

Example 4

i Ä ° l ^m1 '°' ⁰⁵ molar equivalents) and 88% ^{orthophosphoric} Λ P ^h osphorsäure (0.032 ml, 0.05 mole M ^e) Τ "™ ^{1 m} n-propyl given.," Λ "" ^{8 was refluxed} to boiling c ^{»e the Condensate} (10 g) is recycled *, 15 minutes of heating at the return, the mixture was cooled slightly, and in the reaction flask J * l ^{of Calci} umoxyd - rnchlorathyl - 6ss - phenylacetamido - Penicillium

Lanate-1 / f-oxide (4.82 g, 0.01 mol) was added. The mixture was refluxed for 2 hours, concentrated to a small amount and the residue was crystallized from ethanol (12 ml), the 2,2,2 - trichloroethyl - 3 - methyl - 7./Ϊ - pheriylacetamidoceph-S-em - ^ - carboxylate, 3.04 g (65.5% of theory) obtained, melting point = 161 to 162 ° C, [«]" + 512 ° (C, 0.8 in CHCl.,), A _mux ( Ethanol) at 264 mm (E | * 130).

Example 5

IO

ρ - methoxybenzyl - 6ß - phenylacetaniido - penicillanate-1 / i-oxide was converted to p-methoxybenzyl-3-methyl- 7 β - pheny lacetamidoceph - 3 - em - 4 - carboxy la t according to one of the following procedures:

a) A solution of p-methoxybenzyl-öff-phenylacetamidopenicilIanat-1 / i-oxide (9.41g, 20mmol), pyridine (0.16g, 2mmol) and 89% phosphoric acid (0.22g, 2mmol) in dry peroxide-free dioxane (2COmI) was refluxed for 15.25 hours, the condensed vapors being passed through molecular sieves (0.16 cm, 40 g) before being returned to the reaction vessel. Analysis by thin-layer chromatography (benzene-ethyl acetate 2: 1) showed only a trace of the starting 1 / f-oxide when sprayed with iodine azide reagent. The dioxane was removed at 30 ° / 15 mm, giving a brown gel which was triturated with ethyl alcohol (technical denat., 50 ml). The resulting pale brown gel was collected, washed with ethyl alcohol (techn. Denat.) And ether and dried, the p-methoxybenzyl-3-methyl - Ί β- phcnylacetamidoceph - 3 -em -4-carboxylate (6.025 g, 66, 5%), [«]" + 44 ° (C, 1.24, CHCl ₃ ), λ, _ηαχ (EtOH) 228 nm. (Ej * 355) and 264 to 274 nm. (EJ *, 134), NMR (CDCl ₃ ), τ = 7.92 (C ₃ -CH ₃ ). Integration indicated 2.64 protons with respect to τ = 6.22 (C ₆ H ₄ OCH ₃ ). Evaporation of the combined filtrates and washing water and crystallization from ethyl alcohol (techn. Denat.) Ether yielded a second batch of less pure Ceph-3-emester (0.69 g, 7.6%) NMR (CDCl ₃ ), τ = 7.92 . The integration corresponded to 2.25 protons in relation to τ = 6.22.

b) Pyridine (320 mg, 4 mmol) and 89% phosphonic acid (220 mg, 2 mmol) were added to a solution of the ester of the 1 / i-oxide (9.41 g, 20 mmol) in dry, peroxide-free dioxane (200 ml ) and the mixture was heated to reflux for 16 hours with the condensed vapors being passed through a bed of molecular sieves (0.16 cm, 40 g) before being returned to the reaction vessel. Thin-layer chromatographic analysis (benzene-ethyl acetate 1: 1) when sprayed with iodine azide reagent showed that a trace of the starting β-oxide was present, so the reaction mixture was refluxed for a further 4 hours. The dioxane was removed at 30 ° / 15 mm, whereby An orange solid was obtained which was crystallized from boiling methanol (300 ml) to give p-methoxybenzyl-3-methyl-7β-phenylacetamidoceph-3-em-4-carboxylate as needles, which were filtered off with ether (20 ml) washed and dried (5 81 g, 64%), melting point = 151 to 152 ^° C., [α]?

+ 38.5 ° (c 1.00, CHCl ₃ ), _Amni (ethanol) 227 nm. (Ej * 382) and 269 nm (EJ 1 176).

Evaporation of the filtrate and the washing solution to about 100 ml yielded a second batch of Ceph-3-em-ester (0.98 g, 11%), m.p. = 150 to 152 ° C, O]? + 38 ° (c 0.98, CHCl ₃ ), λ _Μαχ (ethanol) 226 nm. (E! *, 361.5) and 269 nm. (Ej * 162).

c) A reaction similar to that described in b), but using pyridine (320 mg, 4 mmol) and monopyridyl dichloromelhane phosphonate (488 mg, 2 mmol) gave an orange-colored gelatinous solid after removal of the dioxane, which was made up of boiling methanol (250 ml ) was crystallized to give the Ceph-3-em-ester in the form of needles, which was filtered off, washed with ether (20 ml) and dried (6.08 g, 67%), mp = 151 to 152 , 5 ° C, [«]? +390 '(c 1.08, CHCl ₃ ). A _11111x (ethanol) 227 nm. (Ej * 392) and 269 nm. (EU 175).

The filtrate and washings were concentrated to about 75 ml, then a gel began to separate out. This was redissolved by heating to reflux. Cooling provided a second batch of the Ceph-3-em ester in the form of needles (1.28 g, 14%), m.p. = 149 to 150.5 "C. [./]: +39 (c 0 , 98, CHCl ₃ ), l _max (ethanol) 227 nm. (EU 375) and 269 nm. (Ej * 164).

Example 6

A solution of phenacyl-6 / i-phenylacetarnidopenicillanate - 1 / i-oxide (1.18 g, 2.5 mmol), pyridine (21 mg, 0.25 mmol) and 89% phosphoric acid (28 mg, 0.25 mmol ) in dry peroxide-free dioxane (50 ml) was refluxed for 27 hours with the condensed vapors being passed through molecular sieves (0.16 cm 40 g) before being returned to the reaction vessel. Analysis by thin-layer chromatography (benzene / ethyl acetate 3: 1) showed only a trace of the starting oxide when sprayed with iodine azide reagent. The dioxane was removed at 30'715 mm and the remaining yellow solid was dissolved in a mixture of ethyl acetate (100 ml) and 2N sulfuric acid (100 ml) with heating. The organic layer was washed with water (100 ml), combined with the ethyl acetate backwash solution of the aqueous layers, dried, and then the solvent was evaporated to give a crystalline solid. This solid was crystallized from ethyl alcohol (technical denat.), Whereby the phenacyl-3-methyl -iss- phenylacetamidoceph-3-em-4-carboxylate (0.56 g, 50%) was obtained, mp = 184 to 190 ⁰ C, [a] "+ 12 ° (C 1.0, CHCl ₃ ), X _max (ethanol; 244 nm (E! * _M 430) with an inflection point at 270 nm. (EJl 162).

Another crystallization from ethyl alcohol (techn. Denat.) Provided the analytical sample, melting point = 190 to 193 ° C, O] ₀ + 7 ° (C 1.0, CHCl ₃ ), X _max (ethanol · 244 nm. (R 19 800) with inflection at 270 nm. ( _F 7480)

Analysis for C ₂₄ H ₂₂ N ₂ O ₅ S = 450.5:

"Calculated ... C 64.0, H 4.9, N 6.2, S 7.1%; found .... C 64.2, H 5.0, N 6.2, S 7.0%.

Example 7

A solution of p-bromophenacyl-6 / i-phenylacetate amido-penicillanate-1 / J-oxide (1.095 g, 2 mmol), Pyri din (16 mg, 0.2 mmol) and 89% phosphoric acid (22 mg, 0.2 mmol) in dry peroxide-free Di

oxane (50 ml) was refluxed for 30 hours. The condensed vapors were passed through molecular sieves (0.16 cm, 40 g) before being returned to the reaction vessel. Thin layer chromatographic analysis (benzyl-ethyl acetate 3: 1) showed no starting material 1 / i-oxide when sprayed with iodine azide reagent. The dioxane was removed at 307.5 mm and the residue was dissolved in a mixture of ethyl acetate (125 ml) and 2N sulfuric acid (125 ml) with warming. The organic layer was washed with water, combined with the ethyl acetate backwashing solution of the aqueous layers, decolorized by stirring with a mixture of anhydrous magnesium sulfate and activated charcoal, and dried, filtered and evaporated. The crystalline residue was recrystallized from hot ethyl alcohol (techn. Denat.), P-Bromophenacyl - 3 - methyl - 7β - phenylacetamidoceph - 3 - em-4-carboxylate (0.50 g, 47%), mp = 194 nm to 198 ⁰ C, [a] ₀ + 8 ° (C 1.05, CHCl _3), X _max (ethanol) 258th (> 25 900).

A further crystallization from ethyl alcohol (techn. Denat.) Afforded the analytical sample, mp. = 196 to 199.5 ⁰ C, [n] ₀ + 9 ° (C 1.0, CHCl _3).

Analysis for C ₂₄ H ₂₁ BrN ₂ O ₅ S = 529.4:

Calculated:

C 54.4, H 4.0, Br 15.1, N 5.3, S 6.1%;
found:

C 54.3, H 4.1, Br 14.9, N 5.0, S 5.8%.

Example 8

2,2.2-trichloroethyl-6 / i-phenylacetamidopenicillanate (4.82 g, 10 mmol), N-methylaniline (0.107 g, 1 mmol) and orthophosphoric acid (specific gravity 1.75, 0.112 g, ImMoI) became isobutyl methyl ketone (200 ml) and the mixture was heated to reflux for 1.25 hours. N-methylaniline (0.107 g, 1 mmol) and orthophosphoric acid (specific gravity 1.75, 0.112 g, 1 mmol) were added, and boiling continued for an additional 2.75 hours.

The solution was cooled to room temperature and washed with water (1 × 100 ml, 1 × 50 ml). The organic layer was evaporated to dryness and the semi-solid residue was dissolved in

Table 1

Ethyl alcohol (20 ml) dissolved. The alcoholic solution was evaporated in a similar manner and the res was triturated with ethyl alcohol (15 ml) to give a crystalline solid. The Mischuni was kept for 16 hours at 0 ⁰ C. The product was collected by filtration, washed with diethyl ether and dried, the 2,2,2-tri chloroethyl-S-methyM / f-phenylacetamidoceph-.Vem-4-carboxylate (1.90 g, 41% of theory) received, Fp ίο = 161 to 162 ° C, [«]? + 51.0 ° (C, 1.0 in CHCl ₃ ).

Example 9

2.2.2 - trichloroethyl - 6 / f - phenylacetamidopenicil lanate M-oxide (14.46 g, 0.03 mmol) in dioxane (300 ml was treated with m-nitrobenzenesophosphonic acid (0.609 g and pyridine (0.24 ml)) and the solution was refluxed for 16 hours. While refluxing, the condensate was bubbled through neutral alumina before being returned to the reaction flask. The reaction mixture was concentrated in vacuo. 30 ml) triturated, cooled to room temperature and stored in the refrigerator for 2 hours. The solid was collected by filtration, washed with ethyl alcohol (technical denat. 10 ml) and diethyl ether (20 ml), and dried at 40 ° C. in vacuo, whereby the 2,2,2-trichloroethyl-3-methyl-7 / i-phenylacetamidoceph-3-em-4-carboxylai (11.32 g, 81.4% of theory) was obtained as a colorless crystalline solid, melting point = 160 up to 162 ° C, [«] <, +52.8 '(C = 0.9 in CHCl ₃ ), k _max (ethanol) at 264 ηm (EJ * 136.5).

Concentration of the mother liquors, followed by Kri

Stallization at 0 ° C. produced a second batch (0.6 ε 4.3%). Mp = 160 to 162 "C, [r,] _r + 52 ° (C = 0.8 ir CHCl ₃ ).

For games 10 to 63

Using various solvents and catalysts, the 2,2,2-trichloroethyl 6ß - phenylacetamidopenicillanate - \ (i - oxide in da: 2,2,2 - trichloroethyl - 3 - methyl - Tji - phenylacetamido ceph-3-em-4- carboxylate under the conditions unc

the yields as given in Table I. convicted.

example catalyst acid MoI.- Solvent Conc time Out No. Equiv. (b. Sdp.) tration d. prey base penicillin as % oxyds the Phosphoric acid ¹ ) theory the same. ¹ ) (%) (Hours.) 10 Pyridine the same. ¹ ) 0.1 Diglyme 5 0.33 45.3 Π the same the same. ¹ ) 0.05 i-pr propionate 5 6th 60.2 12th the same Methanesulfone 0.2 n-butyl acetate 5 6th 49.2 13th the same acid ¹ ) 0.025 ² ) the same 5 1.75 64.9 14th the same phosphorous 0.05 the same 5.0 1.5 47.5. acid 15th the same the same 0.1 Isobutylmethyl 2.5 5 48.4 ketone 16 the same 2x0.125 n-butyl acetate 5.0 6.5 41.4 'I salts of the base not isolated.

-1 An additional 0.025 molar equivalents of the free phosphoric acid were used.

continuation

example catalyst acid Mon! - 1 solvent Conc Line penicillin (Hourly Out No. Equiv. (b. Sdp.i tration C oxyds 1.5 bump base as % (%) 4th the p-toluenesulfone 2.5 theory acid 5 17th Pyride in p-xylene sulfone 0.1 Isobutylmethyl 2.5 48.4 acid ketone 8th 18th the same Pyrophosphorus 0.1 the same 2.5 3.75 48.7 acid ¹ ) 4.0 19th the same Trifluoroacetic acid 0.1 the same 2.5 3.5 41.4 phosphoric acid 2.5 3.25 20th the same the same 0, the same 2.5 3.5 40 ³ ) 21 aniline the same 0, the same 2.5 3.5 44.3 22nd o-chloroaniline the same 0, the same 2.5 3.5 38.8 23 m-chloroaniline the same 0, the same 2.5 3.5 41.8 24 p-chloroaniline the same 0, the same 2.5 4.5 42.5 25th o-methylaniline the same 0, the same 2.5 4.75 45.6 26th m-methylaniline the same 0, the same 2.5 4th 44.2 27 o-methylaniline the same 0, the same 2.5 45.6 28 m-nitroaniline the same 0, the same 2.5 24 44.3 29 m-carboxyaniline Naphthalene- 0, the same 2.5 3.5 40.0 30th m-hydroxyaniline 2-sulfonic acid ■ 0, the same 40.2 31 Pyridine Trifluoroacetic acid 0, the same 2.5 2.0 37.7 phosphoric acid 2.5 6.5 32 the same Dioxane 2.75 49 33 3-bromopyridine the same Isobutylmethyl 2.5 2.3 48.1 the same ketone 2.5 2.3 34 Benzimidazole the same. ¹ ) the same 2.5 6.3 54.3 35 2-methylquinoline the same. ¹ ) the same 2.5 3.75 43.3 36 Isoquinoline the same. ¹ ) the same 2.5 3 68.2 37 3-methylpyridine the same. ¹ ) the same 2.5 3.25 63.1 38 4-methylpyridine Phosphoric acid ¹ ) the same 2.5 ■ 2.5 68.5 39 ' 2-methylpyridine the same. ¹ ) the same 2.5 10.5 47.8 40 2-formylpyridine the same. ¹ ) the same 2.5 2.5 43.2 41 Sulfaniline the same. ¹ ) the same 2.5 2.5 38.8 42 3-acetamido
pyridine
3-acetyl pyridine the same. ¹ ) the same 2.5 66.4 43 4-acetamido
pyridine
4-chloropyridine the same 0.1 the same 2.5 5 55.8 44 Pyridine the same. ¹ ) 0.1 the same 2.5 3.5 32.2 45 4-aldoxime the same 3.5 49.2 46 4-carboxypyridine the same 0.1 the same 2.5 3.75 65.6 4-cyanopyridine the same. ¹ ) 0.1 2.5 7.25 47 4-formylpyridine the same. ¹ ) 0.1 the same 2.5 4.0 56.3 48 Quinoline the same. ¹ ) 0.1 the same 2.5 4.0 43.4 49 4-methylquinoline the same 0.1 the same 2.5 52.8 50 8-hydroxy
quinoline the same. ¹ ) 0.1 the same 2.5 56.8 51 wl 111 Iv ^ 11 11
2-chloropyridine the same. ¹ ) 0.1 the same 2.5 55.2 52 0.1 the same 44.2 53 0.1 the same 44.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0,

¹ ) Salts of the base not isolated.

³ I Estimated from the gross yield of 51.6%.

continuation

/(O

Example catalyst No.

base

MoI equiv.

solvent (B. ScJp.I

acid

Concentration d
Penicillin oxides

time

ih.

Ausheu te
as %
the
theory

54 Pyridine At sp i Methane phosphonic 0.3 Dioxane acid 55 the same Ethane phosphonic 0.3 the same acid 56 the same Iodomethane phosphate 0.1 the same phonic acid 57 the same Trichloromethane 0.05 the same phosphonic acid 58 Pyridine (2 moles) the same 0.05 the same 59 N-methylaniline the same 0.1 the same 60 Benzylamine the same 0.05 the same (2 moles) 61 a-picoline the same 0.075 the same 62 Pyridine o-bromobenzene 0.1 the same phosphonic acid 63 the same Phosphonic acid 0.05 like cools until the I. el 64 Hpn in Λρνη V

5
5
5

5
5

16

22.5

17th

18.5

16

16.5

16

24
18th

11th

42.7
46.8
67.6
60.6

71
39.2

52.1

51

52

76.5

a) A mixture of aluminum chloride (268 g, 2.0 mol), phosphorus trichloride (88 ml, 1.0 mol) and chloroform (160 ml, 2.0 mol) was refluxed for 2 hours. The solution was cooled and poured into methylene chloride (700 ml), the reaction flask was washed out with methylene chloride (2 x 150 ml), and the washings were added to the main solution. The mixture was cooled to -20 ⁰ C and stirred vigorously while water (ml, 14.4 mol 260) was added at such a rate that the temperature close to -5 ° C remained. After the addition was complete, the mixture was warmed to 18 ° C. and stirred for a further 30 minutes. The precipitated aluminum trichloride hexahydrate was filtered off and the filter cake was washed with methylene chloride (1 × 500 ml, 2 × 250 ml). Water (40 ml, 2.2 mol) was added to the methylene chloride solution and the mixture was refluxed for 1 hour to complete the second stage of hydrolysis. The methylene chloride was distilled off and the residue treated with methylene chloride (250 ml), which was distilled off again. The remaining oil was kept under reduced pressure (water jet pump) for 15 minutes in order to remove dissolved HCl. The oil was redissolved in acetone (500 ml), ^{cooled to 0} ° C. and stirred while pyridine (63 ml) was added dropwise. The solid was filtered off and washed with cold acetone (3 × 50 ml) and dried at room temperature in vacuo overnight, the crude monopyridinium dichloromethane phosphonate (197.4 g, 80.4%), melting point 141 ° to 142 ° C.

The crude salt was dissolved in boiling ethyl alcohol (technical denat. 410 ml) with stirring and stored in the refrigerator. The product was collected, washed with acetone (3 × 50 ml) and dried at 40 ° C. in vacuo, giving the monopyridinium dichloromethane phosphonate (188.6 g, 77.3% of theory, calculated on the total yield), mp . = 143 to 145 ^° C. The product did not contain any chloride in ionized form (with silver nitrate in nitric acid there was no turbidity).

Analysis for C ₆ H ₈ Cl ₂ NO ₃ P:

Calculated:

C 29.5, H 3.3, CI 29.1, N 5.7, P 12.7%;
found:

C 29.9, H 3.3, CI 29.1, N 5.9, P 12.3%.

b) 2,2,2 - trichloroethyl - 6 // - phenylacetamidopenicillanate 1 / i-oxide (96.4 g, 0.2 mol) and monopyridinium dichloromethane phosphonate (1.95 g, 0.008 mol) were converted to dioxane (482 ml, treated with basic aluminum oxide) was placed in a 3-necked flask equipped with a stirrer and condenser. The mixture was stirred and heated to reflux with the condensed vapors being returned through sodium hydroxide pellets. The solution was refluxed with stirring for a total of 8 hours until no more starting material was present (TLC). The dioxane was removed in vacuo to give a moist solid. Ethyl alcohol (technical denatured 200 ml) was added and the solid was triturated for a few minutes, giving a uniformly crystalline material. The mixture was kept for 3 hours at 0 ^° C., then the solid was separated off by filtration, washed with ethyl alcohol (technical denat. 100 ml) and ether (100 ml) and vacuumed

dried in a vacuum at room temperature, the 2,2,2 - trichloroethyl - 3 - methyl - 7 /; phenylacetamidoceph-3-em-4-carboxylate (75.1 g, 80.9% of the theoretical yield) was obtained as a colorless crystalline solid, mp = 162 to 165 ° C., corrected, [«] _o + 53 ° (c , 0.91 in CHCl ₃ ), / * ° ^H 264nm {E \ 1 = 130), TLC (benzene / ethyl acetate, 2: 1): one spot R _f 0.65.

The mother liquors were concentrated to give a second batch of the above product (2.3 g, 2.5% of the theoretical yield), mp = 159 to 162 ° C, corrected, [«]" + 53.1 ° (c, 0.97 in CHCl ₃ ), / ™ ^H 264 nm (Ei * = 131), TLC (benzene / ethyl acetate, 2: 1), single spot R _r 0.65.

B e i s ρ i e! 65

2,2,2 - trichloroethyl - 6 / i - phenylacetamidopenicillanate 10-oxide (96.4 g, 0.2 mol), monopyridinium dichloromethane phosphonate (1.708 g, 0.007 mol) and pyridine (0.56 ml, 0.007 mol) were added to Dioxane (482 ml which had been treated with basic alumina) was placed in a three-necked flask equipped with a stirrer and condenser. The reaction and isolation of the product was carried out as in Example 66, the 2,2,2-trichloroethyl-3-methyl-7 / l-phenylacetamidoceph-3-em-4-carboxylate (73.5 g, 79.2 % of the theoretical yield) as a white solid crystalline solid, m.p. = 161.5 to 164.5 ° C., corrected, [«]" +53.9 (c0.91 inCHCl ₃ ), A ^ ^H 264 (Eir _m = 131), TLC benzene, ethyl acetate 2: 1.1 spot R _r 0.65.

A second batch was obtained from the mother liquors (2.74 g, 2.95% of the theoretical yield), melting point = 160 to 162 "C. [«], + 53.9 ° (C 0.95 in CHCl., ), x ^ ° ^H 264nm (E | * = 131), TLC 1 spot.

Example 66

2,2,2 - trichloroethyl - dft - phenylacetamidopenicillanate-1 / i-oj.yd (96.4 g, 0.2 mol) and monopyridinium dichloromethane phosphonate (1.95 g, 0.008 mol) were refluxed in dry peroxide-free dioxane (41 (2 ml) and the condensate was passed through a column of dehydrating agent (sodium hydroxide pellets: 200 g) before being returned to the reaction flask, and the progress of the reaction was monitored by TLC no starting material remained. The solution was cooled to room temperature and poured into water (2.5 l) with stirring. The solid was separated off by filtration, washed with water (2 × 100 ml) and dried in vacuo at room temperature, 2,2,2-trichloroethyl-3-methy 1-7 / f-phenylacetamido-ceph-3-em-4-carboxylate (89.6 g, 96.6% of theory), melting point = 156 ° C, corrected, \ '<i] "+ 58 ° (CHCl ₃ ), k _max (ethanol) 264 nm (Ei * 121).

Example 67

2.2.2 - trichloroethyl - 6 / i - phenylacetamidopenicillanate l / <- oxide (48.2 g, 0.1 mol) and monoisoquinolinium dichloromethane phosphonate (1.471 g, 0.005 mol) in dioxane (482 ml) were reacted ( 8 hours), and the product was isolated as described in Example 66, the 2,2,2-trichloroethyl-3 - methyl - 7 / ί - phenylacetamidoceph - 3 - a - 4 - carb-

60 oxylate (37.02 g, 79.6% of the theoretical yield) obtained, mp = 162 to 164 ° C, corrected, [«] ₀ + 52.1 ° (c 0.8 in CHCl ₃ ), /. £, "" 264 nm (EJ *! 40).

The mother liquors were concentrated to give a second batch of similar material obtained (1.08 g, 2.6% of the theoretical yield), mp. = 159-161 ⁰ C, Mo + 52.4 °.

Example 68

2,2,2 - trichloroethyl - 6 /; - phenylacetamidopenicillanate-1 / i-oxide (48.2 g, 0.1 mol) and mono-3-methylisoquinilium - dichloromethane phosphonate (1.54 g, 0.005 mol) in dioxane (482 ml) were reacted (81.25 hours) , and the product was isolated as described in Example 66, using 2,2,2-trichloroethyl ^ -metbyl ^ / I-phenylacetamidocephO-em-4-carboxylate (30.42 g, 65.5% of the theoretical yield) increased, melting point = 162 to 164 ° C., corrected, [<»]" + 52 ° (c 0.8 in CHCl ₃ ), / ££ ^H 264 nm (E1 * 138).

Example 69

2,2,2-chloroethyl-3-methyl-7 / i-phenoxyacetamidoceph-3-em-4-carboxylate

A solution of 2,2,2-trichloroethyl-6 / i-phenoxyacetamido-penicillanate-1 / i-oxide (2.45 g, 5, OmMoI) in dioxane (dried by passing through basic aluminum oxide, 50 ml) was refluxed heated, the condensed vapors being passed through molecular sieves (30 g) before being returned to the reaction vessel. The mixture was refluxed for 20 minutes and then dichloromethanephosphonic acid monopyridinium salt (0.1345 g, 0.52 mmol, 0.104 equiv.) And pyridine (0.0391 g, 0.50 mmol, 0.100 equiv.) Were added. The mixture was heated for a further 5 ¹ ^ hours under reflux, after which time all starting material was consumed (as determined by TLC to give 2% acetone in methylene chloride as Eluierungsmitte! And a solution of potassium iodide, iodine and potassium used as a developing agent). The dioxane was distilled off under reduced pressure and the yellow oil which remained was dissolved in ethanol (5 ml) and ether (5 ml). Evaporation of this solution to dryness gave a slightly yellow colored solid which, on trituration with ether (10 ml), contained the methanol (0.5 ml), gave the title compound, as a chamois colored solid (1.45 g, 60.5%), m.p. . = 112 to 115 ⁰ C (not corrected), [α]? + 57.2 ° (c, 1.19, CHCl ₃ ). Evaporation of the mother liquor and renewed trituration with ether (2 ml) containing methanol (0.1 ml) gave a second batch as a chamois-colored solid (0.436 g, 18.6%), mp = 105 to 114 ° C (not corrected), [α] έ ⁴ + 53.4 ° (c, 1.20, CHCl ₃ ).

Example 70

tert-butyl-3-methyl-7 / i-phenylacetamidoceph-3-em-4-carboxylate

A solution of tert-butyl-6 / i-phenylacetamidopenicillanate-i / i-oxide (9.28 g, 22.9 mmol) and dipyridinium dichloromethane phosphonate (0.729 g, 2.65 mmol) in dry dioxane (180 ml) was refluxed for 7 hours, with the refluxing dioxane passed through a bed of molecular sieves. The solution was rendered under reduced pressure Evaporated dry, the residue in dichloro

methane (200 ml), washed with saturated aqueous sodium bicarbonate solution (50 ml), water (50 ml), dried (Na ₂ SO ₄ ) and evaporated to dryness in vacuo to give a gelatinous solid (9.83 g) . This solid was stirred with ether (60 ml) for 6 hours at 25 ° C., stored at 4 ° C. for 62 hours and filtered. The residue was washed with ether (30 ml) and dried, the tert-butyl-3-methyl-7 // - phenylacetamidoceph-3-em-4-carboxylate (5.80 g, 15, OmMoI, 65, 5%), m.p. = 120 to 123 ° C, la] ο + 62 ° (c 100, CHCl ₃ ), .- (CHBr ₃ ) 3430 and 3345 (NH), 1780 (/ J-lactam), 1720 (CO ₂ R), 1680 and 1510 cm " ¹ (CONH), τ (CDCl ₃ , 100 MH ₂ ) 8.46 (9-proton singlet, tert-butyl), 7.93 (3-proton singlet, 3-methyl) , 6.53 and 6.91 (2-proton AB quartet, J = 18Hz, S-CH ₂ -). 6.40 (2-proton singlet, PhCH ₂ -), 5.11 (1-proton doublet, J = 47 Hz, 6 H), 4.29 (1 proton doublet of doublets, J = 9 and 4 Hz, 7 H), 3.32 (1 proton doublet, J = 9 Hz, N — H), 2, 73 (5 proton singlet, Ph-), X _max (r) 257.5 (5780) and 263.5 (5780).

Analysis for C ₂₀ H ₂₄ N ₂ O ₄ S:

Calculated .. C 61.8, H 6.2, N 7.2, S 8.2%;
found .. - C 59.9, H 6.2, N 6.8, S 7.9%.

The salts of the phosphonic acids were prepared as follows:.

A 12 5% solution of the acid in the appropriate solvent was treated with the base, which

was added dropwise until no further precipitate formed. The solid was filtered off with the same solvent that the reaction had been used for, washed and ^{dried in vacuo at 20 °} C., the ge

, 5 wanted product received. If necessary, din Samples recrystallized.

The following table shows the salts of the acid RPiOXOH) ₂ which were prepared in this way. All acids shown in the table form

the monobasic salts, with the exception of chloromethanephosphonic acid, which provided a dibasic salt with benzyl lamb.

Acid R = base Solution Fp. salt H upper values N formula medium (corr.) 3.6
3.6 lower values found 2.9
2.5 Cl 5.1
5.0 calculated 5.1
49 34.7
34.7 6.5
6.8 N-methyl
aniline ether 219-220 ° C C. 3.0
3 ,! 38.8
38.2 4.7
4.8 C ₈ H ₁₁ NO ₃ Cl ₃ P Cl ₃ C Pyridine ether 180-184 ° C 31.6
31.3 3.3
3.4
4.0 25.6
25.7 4.4
48 C ₆ H ₇ NO ₃ Cl ₃ P Cl ₃ C- Benzylamine ether 198-202 ° C 25.9
25.9 3.9 36.5
36.4 ^ »**
4.3 C ₁₅ H ₂₀ N ₂ O ₃ Cl ₃ P Cl ₃ C- a-picoline ether 155-157 ° C 43.8
43.5 24.0
24 2 4.6 C ₇ H ₉ NO ₃ Cl ₃ P Cl ₂ CH- Isoquinoline acetone 143-147 ° C 28.3
28.7 23.1 C ₁₀ H ₁₀ NO ₃ Cl ₂ P Cl ₂ CH- 3-methyliso- acetone 147-149 ° C 40.5
40.8.
42.4 23.1 C ₁₁ H ₁₂ NO ₃ Cl ₂ P quinoline 42.8

Claims (1)

Patent claims: 1. Process for the preparation of 7 / K-Acylamido-S-methylceph-S-em - ^ - carboxylic acid esters the general formula Pyridine and one molar equivalent of dichloromethane phosphonic acid is formed. 5. The method according to any one of the preceding claims, characterized in that as an inert organic solvent dioxane is used.